Results 291 to 300 of about 241,963 (315)
Some of the next articles are maybe not open access.
Recent Patents on Inflammation & Allergy Drug Discovery, 2008
The therapy of systemic lupus erythematosus (SLE), a systemic autoimmune disease of unknown aetiology, is significantly complicated by the diversity of disease manifestations and by a variety of complex immune abnormalities. Recent preclinical studies have shown the therapeutic efficacy of several drugs and/or new compounds, some of which have been ...
FERRERA, FRANCESCA +6 more
openaire +4 more sources
The therapy of systemic lupus erythematosus (SLE), a systemic autoimmune disease of unknown aetiology, is significantly complicated by the diversity of disease manifestations and by a variety of complex immune abnormalities. Recent preclinical studies have shown the therapeutic efficacy of several drugs and/or new compounds, some of which have been ...
FERRERA, FRANCESCA +6 more
openaire +4 more sources
Clinics in Rheumatic Diseases, 1982
SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in combination with cytotoxic drugs, merits further exploration as a therapeutic modality.
openaire +2 more sources
SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in combination with cytotoxic drugs, merits further exploration as a therapeutic modality.
openaire +2 more sources
New England Journal of Medicine, 1972
P E, Phillips, M, Reichlin, M, Mattiolo
openaire +2 more sources
P E, Phillips, M, Reichlin, M, Mattiolo
openaire +2 more sources